<!--{{Calgary}}-->
{{:Team:Calgary/NavBar}}

<html lang="en">

<head>
    <meta charset="utf-8">
    <title>Team:Calgary - 2018.igem.org</title>
    <meta name="viewport" content="width=device-width, initial-scale=1">

    <!-- Styles -->
    <link rel="stylesheet" href="http://2018.igem.org/Team:Calgary/WikiResetCSSImposter?action=raw&ctype=text/css">
    <!-- Bootstrap 4's CSS -->
    <!-- <link rel="stylesheet" href="http://2018.igem.org/Team:Calgary/BootstrapMinCSS?action=raw&ctype=text/css"> -->
    <!-- Long Scroll CSS -->
    <link rel="stylesheet" href="http://2018.igem.org/Team:Calgary/JQueryFullPageCSS?action=raw&ctype=text/css">
    <!-- Font Awesome CSS -->

    <!-- UH OH! CDN! -->

    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css">

    <!-- Home Page CSS -->
    <link rel="stylesheet" href="http://2018.igem.org/Team:Calgary/HomePageCSSImposter?action=raw&ctype=text/css">

    <!-- Scripts -->

    <!-- Long Scroll JS -->
    <script src="http://2018.igem.org/Team:Calgary/JQueryMinJSImposter?action=raw&ctype=text/javascript"></script>
    <script src="http://2018.igem.org/Team:Calgary/JQueryFullPageJSImposter?action=raw&ctype=text/javascript"></script>
    <!--<script>
            $(document).ready(function() {
                $('#fullpage').fullpage({
                    anchors: ['Gene Therapy', 'Towards a Safer Gene Therapy','Software', 'Human Practices', 'Contact Us'],
                    sectionsColor: ['#343a40', '#343a40', '#343a40', '#343a40'],
                    navigation: true,
                    navigationPosition: 'right',
                    navigationTooltips: ['Gene Therapy', 'Towards a Safer Gene Therapy', 'Software','Human Practices', 'Contact Us'],
                    css3: true,
                    responsiveWidth: 750,
                    responsiveHeight: 400,
                    loopTop: true,
                    loopBottom: true,
                    afterResponsive: function(isResponsive) {}
                });
            });
        </script>-->
    <!-- Bootstrap 4's JS -->
    <!-- <script src="http://2018.igem.org/Team:Calgary/BootstrapBundleMinJSImposter?action=raw&ctype=text/javascript"> -->
    <link href="https://fonts.googleapis.com/css?family=Quicksand" rel="stylesheet">
</head>
<style>
    p {
        display: none !important;
    }

    .fp-tableCell {
        vertical-align: text-top !important;
    }

    body {
        background-color: #343a40 !important;
        font-family: 'Quicksand', sans-serif;
    }

    #innerContainer {
        position: absolute;
        bottom: 0;
    }

    p2 {
        text-align: left !important;
        font-weight: normal;
        font-family: 'Quicksand', sans-serif;
        color: #E5E7E9;
    }

    .intro {
        padding-top: 8%;
        padding-left: 0 !important;
        padding-right: 0 !important;
        padding-bottom: 0 !important;
        width: 100%;
        height: auto;
        position: relative;
    }

    .intro1 {
        padding-top: 2%;
        padding-left: 2% !important;
        padding-right: 2% !important;
        padding-bottom: 0 !important;
        width: 100%;
        height: auto;
        margin-left: auto;
        margin-right: auto;
        position: relative;

    }

    h1 {
        font-size: 150% !important;
        font-family: 'Quicksand', sans-serif !important;
    }

    h2 {
        font-size: 100%;
        text-align: center;
        font-family: 'Quicksand', sans-serif !important;
    }

    @media only screen and (max-width: 450px) {
        p2 {
            font-size: 100% !important;
        }
        h1 {
            font-size: 150% !important;
        }
        .rowTITLE {
            text-align: center;
            font-size: 150%;
        }
        .row {
            margin: 0;
        }
        .rowMicro {
            text-align: left;
            margin-top: 2%;
            margin-bottom: 2%;
            margin-left: 0%;
            margin-right: 0%;
        }
        .intro {
            margin-top: 25%;
        }
        .geneTherapy {
            height: auto;
            max-width: 100% !important;
        }
    }

    @media only screen and (max-width: 981px min-width: 450px) {
        p2 {
            font-size: 100% !important;
        }
        h1 {
            font-size: 150% !important;
        }
        .rowTITLE {
            text-align: center;
            font-size: 150%;
        }
        h2 {
            font-size: 100%;
            text-align: center;
        }
        .infor {
            text-align: justify;
            margin-top: 10% !important;
            margin-bottom: 2% !important;
        }
        .rowStyle1 {
            margin-right: 3%;
            margin-left: 3%;
        }

        .rowMicro {
            text-align: left;
            margin-top: 2%;
            margin-bottom: 2%;
            margin-left: 0%;
            margin-right: 0%;
        }
        .geneTherapy {
            max-width: 100% !important;
            height: auto;
        }
        .container {
            margin-top: 1%;
            margin-bottom: 1%;
        }
    }

    @media only screen and (min-width:982px) {
        p2 {
            font-size: 100%;
        }
        .rowTITLE {
            text-align: center;
            font-size: 150% !important;
        }
        h2 {
            font-size: 100%;
            text-align: center;
        }
        .rowStyle1 {
            margin-right: 5%;
            margin-left: 5%;
        }
    }

    .geneTherapy {
        height: auto;
        max-width: 50%;
        display: block;
        margin-left: auto;
        margin-right: auto;
        text-align: center !important;
    }

    .container {
        margin-top: 2%;
        margin-bottom: 2%;
        text-align: left;
    }

    .container2 {
        margin-top: 2%;
        margin-bottom: 2%;
    }

    .containerh1 {
        margin-top: 2%;
        margin-bottom: 2%;
    }

    .containercentered {
        margin-top: 2%;
        margin-bottom: 2%;
        text-align: center;
    }

    .row {
        text-align: left;
        margin: 2%;
    }

    .rowMicro {
        text-align: left;
        margin-top: 2%;
        margin-bottom: 2%;
        margin-left: 25%;
        margin-right: 25%;
    }

    .rowpic {
        text-align: center;
    }

    }

    .sectionTitle {
        text-align: center;
        \\font-size: 100%;
        font-family: 'Quicksand', sans-serif !important;
    }

    .containerfluid {
        margin-bottom: 0;
    }

    .infor {
        \\padding: 2%;
    }

    .imgr {
        margin-top: 2%;
        margin-bottom: 2%;
        width: 50%;
        display: block;
        margin-left: auto;
        margin-right: auto;
    }


    .colStyle1 {
        padding-left: 2%;
    }

    .colStyle2 {
        padding-right: 2%;
    }

    .rowpiccenter {
        text-align: center;
    }

    .rowTITLE {
        text-align: center;
        font-size: 150%;
        font-family: 'Quicksand', sans-serif !important;

    }
</style>

<body>

    <!-- Content -->
    <div id="fullpage">
        <!-- Project Preview -->
        <div class="section" id="section0">
            <div class="intro" id="slide0">
                <div class='container-fluid'>
                    <div class='containerh1'>
                        <div class='rowh1'>
                            <div class='col-sm-12'>
                                <h1>What is Gene Therapy?</h1>
                            </div>
                        </div>
                    </div>
                    <div class='container'>
                        <div class='row rowStyle1'>
                            <div class='col-sm-6 infor'>
                                <p2>The ideal medicine is not a perfect treatment - it is a cure. For the first time, humankind
                                    has the tools to correct the genetic causes of disease.</p2>
                            </div>
                            <div class='col-sm-6 infor'>
                                <p2>Gene therapy gives us the opportunity to add, remove, and change our genes, influencing how
                                    protiens are made and better provide care for those who suffer from debilitating diseases.</p2>
                            </div>
                        </div>
                    </div>
                    <div class='container'>
                        <div class='row'>
                            <div class='col-sm-12 infor'>
                                <p2>Typically, gene therapy is performed using a virus to introduce the treatment into the body.
                                    Viruses are greatly successful at penetrating cells, and thus work as an excellent vector
                                    for introducing genetic material. Provided that the treatment is successful, functioning
                                    proteins will be secreted from the repaired cell, as diagrammed below.
                                </p2>
                            </div>
                        </div>
                    </div>
                </div>
                <div class='containercentered'>
                    <div class='rowpiccenter'>
                        <div class='rowpic'>
                            <div class='col-sm-12'>
                                <img src='http://2018.igem.org/wiki/images/c/c0/T--Calgary--GeneTherapy.png' class='geneTherapy'>
                            </div>
                        </div>
                    </div>
                    <div class='row'>
                        <div class='col-sm-12'>
                            <h2>However, paths toward ideals are not without hurdles.</h2>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </div>

    <div class="container">

        <hr>
        <br>

        <h1 style="text-align: center;">How We're Moving Towards a Safer Gene Therapy</h1>

        <div class="row">
            <div class="col-sm-12 infor">
                <p2>While viral vectors have successfully demonstrated the potential of gene therapy, safety concerns, such as
                    the random integration of therapeutic DNA, which can lead to cancer and severe immune responses, constrain
                    their use to severe diseases. In order for gene therapies to benefit a greater number of people, for
                    a wider range of indications, the risks of viral delivery must be overcome. The most pressing issue is
                    the random integration of therapeutic DNA, leading to cancer, and severe immune responses, which both
                    threaten gene therapy's development.
                </p2>
            </div>
        </div>

        <div class="row">
            <div class="col-sm-12 infor">
                <p2>Targeted integration of DNA in mammalian genomes has been made simple with CRISPR/Cas9. Unfortunately, the
                    insertion of large (> 1 kb) DNA inserts has proven too inefficient for therapeutic applications, restricting
                    the use of CRISPR-mediated knock-in to relatively small inserts. In light of these constraints, the University
                    of Calgary iGEM team has designed a targeted gene integration platform to build a safer gene therapy.
                </p2>
            </div>
        </div>

        <div class="row">
            <div class="col-sm-6 infor">
                <p2>There are two pillars at the core of our platform. The first consists of a two-phase integration system,
                    based on CRISPR/Cas9 and Flp recombinase. By inserting small Flp recombinase target (FRT) sites using
                    CRISPR/Cas9, Flp can be used to integrate large inserts. To minimize the risk of off-target effects,
                    we will target a "genomic safe harbor" where DNA can safely be introduced.
                </p2>
            </div>
            <div class="col-sm-6 infor">
                <p2>Furthermore, we are minimizing off-target integration by employing Cas9 nickase with an ssDNA template. This
                    second pillar leverages regulatory elements (REs) found naturally in the human genome to keep therapeutic
                    DNA active and isolated from its genomic context. In particular, we are using ubiquitously- acting chromatin-opening
                    elements (UCOEs) to maintain internal control of transgene expression, while preventing disruption of
                    the host genome with insulators.
                </p2>
            </div>
        </div>

        <hr>
        <br>

        <h1 style="text-align: center;">How Snip, Equip, Flip Works</h1>

        <div class="row">
            <div class="col-sm-12 infor">
                <p2>1. Snip: Paired nicks near the genomic target to initiate DNA repair.</p2>
            </div>
        </div>

        <div class="row">
            <div class="col-12 info">
                <img src="http://2018.igem.org/wiki/images/a/ac/T--Calgary--Snip.png" class="imgr">
            </div>
        </div>

        <div class="row">
            <div class="col-sm-12 infor">
                <p2>2. Equip: Single-stranded DNA as a repair template to introduce distinct target sites.</p2>
            </div>
        </div>

        <div class="row">
            <div class="col-12 info">
                <img src="http://2018.igem.org/wiki/images/c/cc/T--Calgary--Equip.png" class="imgr">
            </div>
        </div>

        <div class="row">
            <div class="col-sm-12 infor">
                <p2>3. Flip: FLP recombinase-mediated cassette exchange (RMCE) between pairs of target sites.</p2>
            </div>
        </div>

        <div class="row">
            <div class="col-12 info">
                <img src="http://2018.igem.org/wiki/images/7/78/T--Calgary--Flip.png" class="imgr">
            </div>
        </div>

    </div>


    <!-- Software Preview -->
    <div class="section" id="section1">
        <div class="intro" id="slide1">

            <hr>
            <br>

            <h1>What is iGEM?</h1>
            <div class='container'>
                <div class='row'>
                    <p2>iGEM, the International Genetically Engineered Machine, is a non-profit organization dedicated to the
                        advancement of synthetic biology. Every year, iGEM holds a competition in Boston where over 300 teams
                        from all over the world come to compete.</p2>
                </div>
            </div>
            <div class='container'>
                <div class='row'>

                    <div class='col-sm-6'>
                        <p2>
                            This year, team Calgary is competing at the iGEM competition in Boston with our project, Snip, Equip, Flip: Towards a Safer
                            Gene Therapy. In preparation for the competition, the team is completing a number of requirements,
                            which include building software solutions and generating a microfluidic system.</p2>
                    </div>
                    <div class='col-sm-6'>
                        <p2>
                            The requirements to succeed in the competition include demonstrating that our engineered system works, collaborating with
                            other teams, and considering the social implications of our system (human practices). </p2>
                    </div>

                </div>
            </div>

            <hr>
            <br>

            <h1>Additional Work</h1>
            <div class='container'>
                <div class='row'>
                    <p2>The dry lab team is developing two tools for making software easily accessible for iGEM teams, as well
                        as exploring microfluidic solutions for delivering gene therapy.</p2>
                </div>
            </div>
            <div class='container'>
                <div class='row'>
                    <div class='col-sm-6 mx-auto'>
                        <div class='rowTITLE'>
                            <div class='text-center'>SARA</div>
                        </div>
                        <div class='row'>
                            <p2>A tool for aggregating software created by past iGEM teams into a readable, editable, and searchable
                                database. SARA (Software Aggregating Research Assistant) is being made available for online
                                and local use. SARA is intended to make software developed by the iGEM community more valuable
                                by improving access and awareness</p2>
                        </div>
                    </div>
                    <div class='col-sm-6 mx-auto'>
                        <div class='rowTITLE'>
                            <div class='text-center'>LARA</div>
                        </div>
                        <div class='row'>
                            <p2>A lab management tool that is compatible with google assistant. The features of LARA (LAb Research
                                Assistant) include step-by-step reading of protocols, a speech to text lab notebook, and
                                access to SARA. LARA is intended to allow for the hands-free exchange of information in a
                                lab, improving the efficiency and ease of lab work.</p2>
                        </div>
                    </div>
                </div>
            </div>
            <div class='container'>
                <div class='row'>
                    <div style="margin: 0 auto" class='col-sm-12 col-md-6'>
                        <div class='rowTITLE'>
                            <div class='text-center'>Microfluidics</div>
                        </div>
                        <!-- <div class='rowMicro'> -->
                        <p2>The applied design group is developing a GMP-in-a-box prototype to deliver the modification method
                            in a clinical setting. This microfluidic system encapsulates target cells in droplets and transfects
                            them via electroporation.</p2>
                    </div>
                    <!-- </div> -->
                </div>
            </div>
        </div>

        <!-- Human Practices Preview -->
        <div class="section">
            <div class="intro">
                <hr>
                <br>

                <h1>Human Practices</h1>
                <div class='container'>
                    <div class='row'>
                        <div class='col-sm-6 mx-auto'>
                            <div class='rowTITLE'>
                                <div class='text-center'>Thought Leaders</div>
                            </div>
                            <div class='row'>
                                <p2>
                                    The team has been reaching out to thought leaders in the community with the goal of mitigating concerns regarding gene therapy.
                                    As a relatively new treatment, gene therapy has been met with mixed reactions. Concerns
                                    range from the ethics of enhancement to the accessibility of the treatment. The team
                                    would like to address two specific concerns: the act of playing god with respect to western
                                    religions, and the relationship between gene therapy treatments and traditional First
                                    Nations medicine practices.
                                </p2>
                            </div>
                        </div>
                        <div class='col-sm-6 mx-auto'>
                            <div class='rowTITLE'>
                                <div class='text-center'>Education</div>
                            </div>
                            <div class='row'>
                                <p2>
                                    While gene therapy and its applications are the focus of the human practices portion, the team is also working towards improving
                                    education in synthetic biology at the high school level. As an emerging science, the
                                    team is working to develop lesson plans and curriculum proposals for Alberta education
                                    and proposing a heavier focus on synthetic biology for the international baccalaureate
                                    (IB) curriculum, which operates all over the world.
                                </p2>
                            </div>
                        </div>
                    </div>
                </div>
                <div class='container'>
                    <div class='row'>
                        <div class='col-sm-6 mx-autp'>
                            <div class='rowTITLE'>
                                <div class='text-center'>Ethics and Safety</div>
                            </div>
                            <div class='row'>
                                <p2>
                                    As with all new technology there are increased points of risk that need to be addressed. Particularly, the team has taken
                                    strides to increase awareness of the safety precautions that should be taken, while also
                                    implementing safeguards where possible. Careful consideration of the ethical implications
                                    of gene therapy through introspection is being done and extended via discussions with
                                    individuals in the realm of bioethics. These accounts inform our work along with meetings
                                    with the public, stakeholders and thought leaders.</p2>
                            </div>
                        </div>
                        <div class='col-sm-6 mx-auto'>
                            <div class='rowTITLE'>
                                <div class='text-center'>Business Logistics</div>
                            </div>
                            <div class='row'>
                                <p2>
                                    The team is addressing the project in its clinical context. Meetings at Innovate Calgary are useful for consideration of
                                    the project's value from a product level view. The team is also speaking with clinicians
                                    and genetic counselors, who are the primary liason between the laboratory, our product,
                                    and patients. Collectively these meetings ground our work in reality, and allow us to
                                    enage meaningfully with potential stakeholders in our project. </p2>
                            </div>
                        </div>
                    </div>
                </div>







            </div>
        </div>

        <!-- Social Media -->
        <!--<div class="section" id="section3">
                <div class="intro" id="slide3">

<hr>
<br>

                    <h1>Contact Us</h1>
                    <ul id="social-media-list">
                        <li><a href="#"><img src="http://2018.igem.org/wiki/images/0/0e/T--Calgary--fb.png" style="height:2.4em"><span>Facebook</span></a></li>
                        <li><a href="#"><img src="http://2018.igem.org/wiki/images/3/34/T--Calgary--insta.png" style="height:2.4em"></i><span>Instagram</span></a></li>
                        <li><a href="#"><img src="http://2018.igem.org/wiki/images/8/84/T--Calgary--twitter.png" style="height:2.4em"><span>Twitter</span></a></li>
                        <li><a href="#"><img src="http://2018.igem.org/wiki/images/4/46/T--Calgary--mail.png" style="height:2.4em"><span>Email</span></a></li>
                    </ul>
                </div>
            </div>-->
        <html>


        <!--

<div class="column full_size" >



</div> 


<div class="column full_size" >

<h3>Before you start</h3>
<p> Please read the following pages:</p>
<ul>
<li>  <a href="http://2018.igem.org/Competition">Competition Hub</a> </li>
<li> <a href="http://2018.igem.org/Competition/Deliverables/Wiki">Wiki Requirements page</a></li>
<li> <a href="http://2018.igem.org/Resources/Template_Documentation">Template documentation</a></li>
</ul>
</div>


<div class="clear extra_space"></div>
<div class="line_divider"></div>
<div class="clear extra_space"></div>



<div class="column full_size" >	
<h3> Styling your wiki </h3>
<p>You may style this page as you like or you can simply leave the style as it is. You can easily keep the styling and edit the content of these default wiki pages with your project information and completely fulfill the requirement to document your project.</p>
<p>While you may not win Best Wiki with this styling, your team is still eligible for all other awards. This default wiki meets the requirements, it improves navigability and ease of use for visitors, and you should not feel it is necessary to style beyond what has been provided.</p> 

</div>




<div class="clear extra_space"></div>



<div class="column third_size" >	

<h3> Uploading pictures and files </h3>
<p> You must upload any pictures and files to the iGEM 2018 server. Remember to keep all your pictures and files within your team's namespace or at least include your team's name in the file name. </p>


<p>When you upload, set the "Destination Filename" to <b> T--YourOfficialTeamName--NameOfFile.jpg</b>. (If you don't do this, someone else might upload a different file with the same "Destination Filename", and your file would be erased!)</p>

<div class="button_link">
<a href="http://2018.igem.org/Special:Upload">
UPLOAD FILES
</a>
</div>

</div>

<div class="column third_size" >	
<h3> Wiki template information </h3>
<p>We have created these wiki template pages to help you get started and to help you think about how your team will be evaluated. You can find a list of all the pages tied to awards here at the <a href="http://2018.igem.org/Judging/Pages_for_Awards">Pages for awards</a> link. You must edit these pages to be evaluated for medals and awards, but ultimately the design, layout, style and all other elements of your team wiki is up to you!</p>

</div> 



<div class="column third_size" >
<div class="highlight decoration_B_full">	
<h3> Editing your wiki </h3>
<p>On this page you can document your project, introduce your team members, document your progress and share your iGEM experience with the rest of the world! </p> 
<p>Use WikiTools - Edit in the black menu bar to edit this page</p>

<div class="button_link">
 <a href="http://2018.igem.org/wiki/index.php?title=Team:Calgary&action=edit"> 
EDIT PAGE
</a>
</div>


</div>
</div>





<div class="clear extra_space"></div>
<div class="line_divider"></div>
<div class="clear extra_space"></div>



<div class="column two_thirds_size" >	
<h3>Tips</h3>
<p>This wiki will be your team’s first interaction with the rest of the world, so here are a few tips to help you get started: </p>
<ul>
<li>State your accomplishments! Tell people what you have achieved from the start. </li>
<li>Be clear about what you are doing and how you plan to do this.</li>
<li>You have a global audience! Consider the different backgrounds that your users come from.</li>
<li>Make sure information is easy to find; nothing should be more than 3 clicks away.  </li>
<li>Avoid using very small fonts and low contrast colors; information should be easy to read.  </li>
<li>Start documenting your project as early as possible; don’t leave anything to the last minute before the Wiki Freeze. For a complete list of deadlines visit the <a href="http://2018.igem.org/Calendar">iGEM 2018 calendar</a> </li>
<li>Have lots of fun! </li>
</ul> 
</div>


<div class="column third_size">
<div class="highlight decoration_A_full">		
<h3>Inspiration</h3>
<p> You can also view other team wikis for inspiration! Here are some examples:</p>
<ul>
<li> <a href="http://2014.igem.org/Team:SDU-Denmark/"> 2014 SDU Denmark </a> </li>
<li> <a href="http://2014.igem.org/Team:Aalto-Helsinki">2014 Aalto-Helsinki</a> </li>
<li> <a href="http://2014.igem.org/Team:LMU-Munich">2014 LMU-Munich</a> </li>
<li> <a href="http://2014.igem.org/Team:Michigan"> 2014 Michigan</a></li>
<li> <a href="http://2014.igem.org/Team:ITESM-Guadalajara">2014 ITESM-Guadalajara </a></li>
<li> <a href="http://2014.igem.org/Team:SCU-China"> 2014 SCU-China </a></li>
</ul>
</div>
</div>
-->



        </html>